Yang J - Search Results

1

PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas.

Shen J, Yang J, Sang L, Sun R, Bai W, Wang C, Sun Y, Sun J. Shen J, et al. Among authors: yang j. Cancer Biol Med. 2021 Sep 28;19(8):1211-23. doi: 10.20892/j.issn.2095-3941.2020.0294. Cancer Biol Med. 2021. PMID: 34570440 Free PMC article.

2

APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.

Yang J, Yang D, Cogdell D, Du X, Li H, Pang Y, Sun Y, Hu L, Sun B, Trent J, Chen K, Zhang W. Yang J, et al. Among authors: yang d. Technol Cancer Res Treat. 2010 Apr;9(2):161-9. doi: 10.1177/153303461000900205. Technol Cancer Res Treat. 2010. PMID: 20218738 Free article.

3

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.

Yang J, Yang D, Sun Y, Sun B, Wang G, Trent JC, Araujo DM, Chen K, Zhang W. Yang J, et al. Among authors: yang d. Cancer. 2011 Nov 1;117(21):4925-38. doi: 10.1002/cncr.26116. Epub 2011 Apr 14. Cancer. 2011. PMID: 21495021 Free PMC article.

4

Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.

Yang J, Ylipää A, Sun Y, Zheng H, Chen K, Nykter M, Trent J, Ratner N, Lev DC, Zhang W. Yang J, et al. Clin Cancer Res. 2011 Dec 15;17(24):7563-73. doi: 10.1158/1078-0432.CCR-11-1707. Epub 2011 Oct 31. Clin Cancer Res. 2011. PMID: 22042973 Free PMC article.

5

Mesenchymal to epithelial transition in sarcomas.

Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang W. Yang J, et al. Eur J Cancer. 2014 Feb;50(3):593-601. doi: 10.1016/j.ejca.2013.11.006. Epub 2013 Nov 28. Eur J Cancer. 2014. PMID: 24291235 Review.

6

BRAF mutation and its inhibitors in sarcoma treatment.

Liu H, Nazmun N, Hassan S, Liu X, Yang J. Liu H, et al. Among authors: yang j. Cancer Med. 2020 Jul;9(14):4881-4896. doi: 10.1002/cam4.3103. Epub 2020 May 31. Cancer Med. 2020. PMID: 32476297 Free PMC article. Review.

7

Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.

Liao Z, Li T, Zhang C, Liu X, Xing R, Teng S, Yang Y, Zhao G, Bai X, Zhao J, Yang J. Liao Z, et al. Among authors: yang y, yang j. Cancer Biol Med. 2020 May 15;17(2):501-512. doi: 10.20892/j.issn.2095-3941.2019.0397. Cancer Biol Med. 2020. PMID: 32587785 Free PMC article. Clinical Trial.

8

The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma.

Lu J, Li T, Liao Z, Yu H, Zhao Y, Wu H, Ren Z, Zhao J, Xing R, Teng S, Yang Y, Li X, Chen K, Trent J, Yang J. Lu J, et al. Among authors: yang y, yang j. Cancer Biol Med. 2021 Nov 25;19(6):910-30. doi: 10.20892/j.issn.2095-3941.2021.0270. Cancer Biol Med. 2021. PMID: 34817950 Free PMC article.

9

Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting.

Yang J, Xu Y, Chen Y, Li T, Zhang X, Hu T, Xing R, Yang Y. Yang J, et al. Among authors: yang y. Cancer Biol Med. 2022 Nov 1;19(10):1496-502. doi: 10.20892/j.issn.2095-3941.2022.0394. Cancer Biol Med. 2022. PMID: 36350007 Free PMC article. No abstract available.

10

Deep insight into the B-cell associated tertiary lymphoid structure and tumor immunotherapy.

Yang J, Xu J, Liu H, Xiao W, Zhang G. Yang J, et al. Cancer Biol Med. 2023 Nov 30;21(2):125-31. doi: 10.20892/j.issn.2095-3941.2023.0308. Cancer Biol Med. 2023. PMID: 38038337 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92,129 results

Search Page

Filters